YAP1 and metabolic dysfunction-associated steatohepatitis: In humans, analysis of liver biopsies from patients with MASH often reveals increased nuclear localization of YAP/TAZ in hepatocytes compared to healthy liver tissues (Mooring et al. 2020; Salloum et al. 2021).